Healing & Repair
Preclinical research overviews of cytoprotective and regeneration-focused peptides — including BPC-157, TB-500, GHK-Cu, KPV, LL-37, and thymosin beta-4 — with mechanisms, findings, and research limitations.
GHK-Cu: What the Copper Peptide Research Shows
GHK-Cu is a naturally occurring copper-binding tripeptide studied extensively in cell culture and animal models for its signaling properties. Here is what the current preclinical literature shows.
BPC-157 Research: What Preclinical Studies Reveal About This Pentadecapeptide
BPC-157 is a synthetic 15-amino-acid peptide studied extensively in animal and cell-culture models. Here is what the published preclinical literature reports — and what researchers still need to establish.
TB-500 Research: What Preclinical Studies Reveal About the Thymosin Beta-4 Fragment
TB-500 is a synthetic fragment of Thymosin Beta-4, studied in preclinical models for its effects on actin dynamics, cell migration, and tissue remodeling. Here is what the research literature currently shows — and where significant gaps remain.
LL-37 Peptide Research: Investigating the Science Behind a Multifunctional Antimicrobial Host-Defense Peptide
LL-37 is a human cathelicidin-derived antimicrobial peptide extensively studied in preclinical models for its roles in host defense, immune modulation, and tissue repair. This overview surveys the current state of laboratory research.
Thymosin Beta-4 Explained: The Parent Peptide Behind TB-500
Thymosin beta-4 is a 43-amino acid peptide studied in preclinical models for its role in actin regulation, cellular migration, and tissue repair signaling. It is the parent molecule from which the research fragment TB-500 is derived.
BPC-157 vs TB-500: How the Preclinical Research Compares
BPC-157 and TB-500 are two of the most researched repair-oriented peptides in preclinical literature. This article places their mechanisms, tissue-model findings, and research limitations side-by-side.
BPC-157 and the Nitric Oxide System: What Preclinical Research Reveals
Preclinical studies have examined how BPC-157 interacts with the nitric oxide signaling system, including NO synthase pathways and vascular tone. Here is what the animal and cell-culture research currently shows.
KPV Peptide: A Review of Inflammation-Related Research
KPV is a tripeptide fragment of alpha-MSH studied in preclinical models for its interactions with inflammatory pathways. This overview summarizes what researchers have observed in cell culture and animal studies.
Copper Peptides in Research: Beyond GHK-Cu and the Expanding Science
GHK-Cu may be the best-known copper-binding tripeptide, but researchers are investigating a growing family of copper peptide complexes with distinct biological activities in cell culture and animal models.
